CATALYST PHARMACEUTICALS, INC. et al v. LUPIN LTD. et al > Summary
Court Case Number 2:23-cv-01197
Filing Date Mar 1, 2023
Court New Jersey District Court
Status Unknown
Plaintiff Attorneys
12SERB
Attorney Name: Dennies Varughese
Sterne, Kessler, Goldstein & Fox
Catalyst Pharmaceuticals
Attorney Name: Christine A. Gaddis
Gibbons P.C.
SERB
Attorney Name: Charles H. Chevalier
Gibbons P.C.
SERB
Attorney Name: Christopher M. Gallo
Sterne, Kessler, Goldstein & Fox
SERB
Attorney Name: Joseph H. Kim
Sterne, Kessler, Goldstein & Fox
SERB
Attorney Name: Paul A. Ainsworth
Sterne, Kessler, Goldstein & Fox
SERB
Attorney Name: Davin Guinn
Sterne, Kessler, Goldstein & Fox
SERB
Attorney Name: Lauren A. Watt
Sterne, Kessler, Goldstein & Fox
SERB
Attorney Name: Adam C. Larock
Sterne, Kessler, Goldstein & Fox
SERB
Attorney Name: Ryan Conkin
Sterne, Kessler, Goldstein & Fox
SERB
Attorney Name: Alexander V. Alfano
Sterne, Kessler, Goldstein & Fox
SERB
Attorney Name: Josephine J. Kim
Sterne, Kessler, Goldstein & Fox
Defendant Attorneys
5Lupin Pharmaceuticals
Attorney Name: James Richter
Midlige Richter
Lupin Pharmaceuticals
Attorney Name: Zhibin Li
Locke Lord
Lupin Pharmaceuticals
Attorney Name: Nina J. Vachhani
Locke Lord
Lupin Pharmaceuticals
Attorney Name: Keith D. Parr
Locke Lord
Lupin Pharmaceuticals
Attorney Name: Jacob C. Britz
Locke Lord
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 11274331 | Methods of administering 3,4-diaminopyridine | Mar 15, 2022 |
| 11274332 | Methods of administering 3,4-diaminopyridine | Mar 15, 2022 |
| 11268128 | Methods of administering 3,4-diaminopyridine | Mar 8, 2022 |
| 11060128 | Methods of administering 3,4-diaminopyridine | Jul 13, 2021 |
| 10793893 | Methods of administering 3,4-diaminopyridine | Oct 6, 2020 |
| 10626088 | Determining degradation of 3,4-diaminopyridine | Apr 21, 2020 |
